Healthy, Human Papilloma Virus Infection
Conditions
Keywords
HPV, Ohio Appalachia, HPV vaccine, No evidence of disease
Brief summary
This clinical trial studies an educational intervention for parents and providers in increasing human papillomavirus (HPV) vaccination rates in younger girls in Ohio Appalachia. Educational interventions may be effective in increasing the number of participants whose daughters receive HPV vaccination.
Detailed description
PRIMARY OBJECTIVES: I. Implement a multi-level HPV vaccine educational intervention directed at 3 levels within participating 12 Ohio Appalachia counties that includes information about cervical cancer, cervical cancer screening, HPV, the HPV vaccine, communication skills training to improve parent-health care provider conversations about the HPV vaccine, and organizational level components. II. Evaluate the effectiveness of the multi-level HPV vaccine educational intervention in a group randomized controlled trial in 12 Ohio Appalachia counties. OUTLINE: Participants are randomized to 1 of 2 arms. Arm I: Parents and health care providers receive educational materials about HPV vaccination by mail or in-person review with project staff including a culturally tailored HPV and cervical cancer educational video and brochures, a question and answer (Q & A) fact sheet, and a HPV and cervical cancer resource list. Clinics receive waiting and exam room posters and brochures, tabletop cards, reminder cards to mail to participants, an information resource list, newsletter, vaccine tracking system, and invitation to be vaccinated letter to mail to parents. Arm II: Parents and health care providers receive educational materials about influenza vaccination by mail or in-person review with project staff. After completion of study, participants are followed up at 3 and 6 months.
Interventions
OTHEReducational intervention
Receive HPV vaccination educational materials
Sponsors
Ohio State University Comprehensive Cancer Center
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* LEVEL 1: Parents * Be able to speak, read, and write English * Has a daughter who receives care from or lives in one of 12 Ohio Appalachia counties * Be a parent or a guardian of a young girl (age 9 to 17 years) who has not received the HPV vaccine (if a parent has more than one daughter, they will be asked questions about their eldest daughter) * Not have a child who has received the HPV vaccine LEVEL 2: Health care providers * Practicing in a participating public health department or provider office in Ohio Appalachia * Personnel involved in the vaccine process (determined by individual health departments or clinic) * Able to speak, read, and write English
Exclusion criteria
LEVEL 1: Parents * Not able to speak, read, and write English * Does not have a daughter who receives care from or lives in one of 12 Ohio Appalachia counties * Not the parent or a guardian of a young girl (age 9 to 17 years) who has not received the HPV vaccine (if a parent has more than one daughter, they will be asked questions about their eldest daughter) * Has a child who has received the HPV vaccine LEVEL 2: Health care providers * Does not practicing in a participating public health department or provider office in Ohio Appalachia * Personnel that is not involved in the vaccine process (determined by individual health departments or clinic) * Not able to speak, read, and write English
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Proportion of daughters of participating parents who received their first HPV vaccination | Within 3 months of viewing educational material | A logistic random effects model will be used. A t-test of the coefficient for intervention status will be used to determine if there is a difference in the expected proportion of vaccinated patients across treatment arms. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Proportion of daughters of participants in the intervention arm who received a second and third dose of the HPV vaccine | Up to 6 months | Separate logistic random effects models will be fit for each vaccination and t-tests of the fixed intervention effect will be used to compare treatment arms. |
Countries
United States
Outcome results
None listed